Canada explains expectations under post-market reporting inspections
This article was originally published in SRA
Health Canada is seeking feedback on a draft guidance document describing the expectations of inspectors conducting post-market reporting compliance (PMRC) inspections1. In addition, comments are being sought on a revised, draft version of a related guidance.
You may also be interested in...
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.
Existing importers and manufacturers of certain medical devices can continue marketing their products for six months or until the Indian medtech regulator makes a final decision on their pending licensing applications.
Differences between how Australia and the EU define “central circulatory system” has resulted in different risk classification levels being assigned to some devices in the two jurisdictions.